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One mechanism by which dengue (DEN) virus may cause cell death is apoptosis. In this study, we investigated whether
the genetic determinants responsible for acquisition by DEN type 1 (DEN-1) virus of mouse neurovirulence interfere with the
induction of apoptosis. Neurovirulent variant FGA/NA d1d was generated during the adaptation of the human isolate of
DEN-1 virus strain FGA/89 to grow in newborn mouse brains and mosquito cells in vitro [Despre`s, P. Frenkiel, M.-P. Ceccaldi,
P.-E. Duarte Dos Santos, C. and Deubel, V. (1998) J. Virol., 72: 823–829]. Genetic determinants possibly responsible for mouse
neurovirulence were studied by sequencing the entire genomes of both DEN-1 viruses. Three amino acid differences in the
envelope E protein and one in the nonstructural NS3 protein were found. The cytotoxicity of the mouse-neurovirulent DEN-1
variant was studied in different target cells in vitro and compared with the parental strain. FGA/NA d1d was more pathogenic
for mouse neuroblastoma cells and attenuated for human hepatoma cells. Changes in virus replicative functions and virus
assembly may account, in a large part, for the differences in the induction of apoptosis. Our data suggest that identified amino
acid substitutions in the envelope E protein and viral RNA helicase NS3 may influence DEN-1 virus pathogenicity by altering
viral growth. © 2000 Academic PressKey Words: dengue virus; envelope protein; RNA helicase; mouse neuron; human hepatocyte; mosquito; pathogenicity;
genetic determinant of virulence; apoptotic cell death.
INTRODUCTION
Dengue (DEN) is the most important vector-borne viral
disease in tropical countries (Henchal and Putnak, 1990;
Gubler and Trent, 1994). It is caused by four serotypes of
the dengue virus (DEN-1, -2, -3, and -4), a member of the
Flavivirus genus (family Flaviviridae), transmitted to hu-
mans by Aedes (Ae) aegypti mosquitoes. It causes a
spectrum of illnesses, ranging from a flu-like disease
(DEN fever) to DEN hemorrhagic fever (DHF), a fulminat-
ing illness that can progress to DEN shock syndrome
(DSS) and death (Henchal and Putnak, 1990; Marianneau
et al., 1998a; Rigau-Pe´rez et al., 1998). The clinical fea-
tures of severe DEN disease include hemorrhagic dia-
thesis, liver involvement, and encephalopathy (Rigau-
Pe´rez et al., 1998; Salomon et al., 2000). The major
pathophysiological change that determines the severity
The nucleotide sequences reported in this study have been submit-
ted to the GenBank Data Library under accession numbers AF 226686
(FGA/NA d1d) and AF 226687 (FGA/89).
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292of disease in DHF is the leakage of plasma. The patho-
genesis of DHF is not well understood. Cytokine produc-
tion and T-lymphocyte activation appear to be important
in the pathogenesis of DHF (Rothman and Ennis, 1999;
Green et al., 1999). The severity of the disease may also
be due to the intrinsic biological properties of the infect-
ing strains of DEN virus (Rico-Hesse et al., 1997, 1998;
Leitmeyer et al., 1999).
The DEN virion is composed of three structural pro-
teins, designated C (core protein), M (membrane pro-
tein), and E (envelope protein) (Chambers et al., 1990;
Rice, 1996). Protein E, which is exposed on the surface of
the virus particle, is responsible for the main biological
functions of the virion, including virus attachment and
virus-specific membrane fusion in acid pH endosomes
(Chambers et al., 1990; Rice, 1996). The genomic RNA is
translated to give rise to a large polyprotein precursor,
which is cotranslationally processed by host-cell and
virus-specified proteases to yield the individual viral pro-
teins. The structural proteins are C, prM (the glycosy-
lated precursor of the M protein), and E, and the non-
structural (NS) proteins are NS1, NS2A, NS2B, NS3,
NS4A, NS4B, and NS5 (Chambers et al., 1990; Rice,
1996). Flavivirus replication occurs within the cytoplasm
of infected cells (Mackenzie et al., 1999). A model for the
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has been recently proposed (Khromykh et al., 1999a, b).
The first steps of DEN virus assembly take place in
association with the membranes of the endoplasmic
reticulum (ER) (Chambers et al., 1990; Rice, 1996). The
EN virion is first assembled as an immature particle
hat contains prM noncovalently associated with E in a
eterodimeric complex (Chambers et al., 1990; Despre`s
t al., 1996; Rice, 1996; Courageot et al., 2000). Proteol-
sis of prM leads to the formation of homodimeric forms
f E in virus particles before their release from the cell
Rice, 1996).
Recombination between different subtypes of DEN vi-
us has been suggested to produce new, biologically
uccessful strains (Holmes et al., 1999; Worobey et al.,
1999). South American DEN-1 virus strain FGA/89 iso-
lated in 1989 from a woman with DF appeared to be a
descendant of a single recombinant ancestor produced
by genetic exchanges between DEN-1 viruses of two
different subtypes (Despre`s et al., 1993; Holmes et al.,
1999). It is assumed that the intrinsic biological proper-
ties of the infecting virus strains could contribute to the
pathogenicity of DEN virus (Despre`s et al., 1993, 1996,
1998; Edelman et al., 1994; Kinney et al., 1997; Bhamara-
pravati and Yoskan, 1997; Bray et al., 1998; Mangada and
Igarashi, 1998). Low-passaged DEN-1 virus isolate
FGA/89 was initially selected on the basis of its biolog-
ical properties and neurovirulence for newborn mice
(Despre`s et al., 1996, 1998).
There is growing evidence that DEN-1 virus infection
triggers apoptotic cell death (Despre`s et al., 1996, 1998;
Marianneau et al., 1997, 1998b, 1999; Couvelard et al.,
1999). Recently, we reported that the infection of mouse
neuroblastoma and human hepatoma cell lines with
DEN-1 virus strain FGA/89 induced cell death typical of
apoptosis (Despre`s et al., 1996, 1998; Marianneau et al.,
1997, 1998b). It has also been suggested that the induc-
tion of apoptosis in human hepatocytes infected with
DEN virus is a major cause of hepatic failure in cases of
DHF-DSS (Marianneau et al., 1997, 1998a, b; Couvelard et
l., 1999).
DEN virus infection of the mouse central nervous sys-
em (CNS) has been used as a model system for the
haracterization of genetic determinants and viral factors
nvolved in the pathogenicity of DEN-1 virus (Despre`s et
T
Positions of Amino Acid Differen
Virus
FGA/89 Met196 ATG Va
FGA/NA d1d Val196 G•• Il
DETERMINANTS OF Dl., 1996, 1998; Lee et al., 1997; Bray et al., 1998). Serial
assaging of FGA/89 in mouse brain and a mosquito cell
c
mine selected a highly neurovirulent variant, FGA/NA d1d,
hich replicates more efficiently in the CNS (Despre`s et
l., 1998). Apoptosis has been shown to be the mecha-
ism by which FGA/NA d1d infection causes neuronal
ell death in the mouse CNS (Despre`s et al., 1998). Here,
e used FGA/89 and its mouse-neurovirulent variant,
GA/NA d1d, to identify the determinants that may be
elevant to DEN-1 virus pathogenicity.
RESULTS
enetic relationships between FGA/89 and its mouse
eurovirulent variant
Complete sequencing of the genome of the mouse-
assaged, neurovirulent variant of FGA/89 allowed iden-
ification of the amino acid changes that are potentially
esponsible for acquisition of mouse neurovirulence. The
9 and 39 untranslated regions (UTRs) of FGA/NA d1d
nd FGA/89 are identical. The amino acid sequences of
he C and prM proteins of the two DEN-1 virus variants
re also identical (Despre`s et al., 1998).
FGA/NA d1d E protein has three amino acid substitu-
ions: at positions 196, 365, and 405 (Table 1; Despre`s et
l., 1998). Only the Ile-for-Thr difference at position E405
ntroduces a significant change in the character of the
esidue. To investigate the structural consequences of
he amino acid substitutions, a three-dimensional model
or the ectodomain of FGA/89 E protein was derived by
omology to the known high-resolution structure of pro-
ein sE (lacking the stem anchor region of E) from tick-
orne encephalitis (TBE) virus (Rey et al., 1995). As in the
tructure of the TBE-sE protein, the polypeptide chain of
EN-1-sE is predicted to fold into three distinct domains:
he central domain I, the dimerization domain II, and the
-terminal module domain III (Rey et al., 1995). The
onservative amino acid substitution at E196 maps to the
nterface of domains I and II (Fig. 1A, yellow and red
omains) in a region that has been proposed to act as a
inge during the fusogenic conformational change of the
rotein (Rey et al., 1995). The conservative amino acid
ubstitution at E365 maps to the interface between do-
ains I and III (Fig. 1A, red and blue domains). The
g-like domain III (Fig. 1A, blue domain) has been impli-
ated in receptor recognition (Rey et al., 1995). The non-
tween FGA/89 and FGA/NA d1d
NS3
TC Thr405 ACC Leu435 TTA
•• Ile405 •T• Ser435 •C•
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s).acids 399–412) (Allison et al., 1999) of the stem region
(adjacent to the membrane-spanning segment), which is
not present in the TBE-sE fragment. The H1pred in the
stem region has been shown to be required for the
conversion of the E protein from homodimers to homotri-
mers (Allison et al., 1999), a process that also takes place
uring the acid pH-triggered fusogenic conformational
hange of E.
Complete sequencing of the NS1–NS5 protein-coding
enes identified only one amino acid substitution in the
onstructural protein NS3 (Table 1). NS3 has several
ctivities associated with virus replication, including
TPase, helicase, and triphosphatase, which are located
ithin a large C-terminal domain (Kapoor et al., 1995;
hen et al., 1997; Li et al., 1997; Cui et al., 1998). The
onconservative Leu435-to-Ser substitution maps to the
helicase domain of NS3. The available crystal structure
FIG. 1. Diagrammatic representation of the structures of the DEN-1-s
based on the high-resolution crystal structure of the TBE-sE protein (
omain (II) is shown in red, and the C-terminal domain (III) is shown
ubstitutions in FGA/NA d1d E protein. N and C label the N- and C-te
CV NS3. The long b-hairpin emerging from the RNA binding domain
position 438 in HCV NS3 protein (equivalent to NS3-435 in DEN-1 viru
294 DUARTE DOof the hepatitis C virus (HCV) NS3 helicase domain (Yao
et al., 1997; Kim et al., 1998; Cho et al., 1998) was used to
p
cposition the amino acid change in FGA/NA d1d NS3
protein in the context of the folded protein. The identity
between the NS3 proteins of DEN-1 virus and HCV is
about 25% for a segment of roughly 500 amino acids
encompassing the respective NTPase–helicase domain.
The alignment is facilitated by the fact that there are
conserved sequence elements scattered throughout the
NS3 proteins. The Leu435-to-Ser change in FGA/NA d1d
S3 protein (NS3-438 in HCV) is located between the
onserved 423VID tripeptide (425VID in HCV) and sequence
454SAAQRRGRIGR (457SxxQRRGRxGR in HCV), encom-
passing motif VI of superfamily II RNA helicases (Gor-
balenya and Koonin, 1993; Kadare and Haenni, 1997;
Grassman et al., 1999). Interestingly, the intervening seg-
ment between these two elements forms a long b-hairpin
that emerges from the RNA-binding domain (Fig. 1B, red
segment). The tip of this long b-hairpin contains hydro-
in and the HCV RNA helicase domain. (A) The E protein was modeled
al., 1995). The central domain (I) is shown in yellow, the dimerization
e. The gray spheres indicate the locations of two of the amino acid
f the polypeptide chain, respectively. (B) The RNA helicase domain of
n in red. The blue sphere indicates the location of the amino acid at
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S SANhobic residues that pack against the core of the adja-
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Substitutions in DEN-1 virus E protein during mouse
brain tissue–specific adaptation may change the affinity
of binding to receptors on target cells or affect the entry
of virions by altering the fusion-regulating structural
change within the virus particle (McMinn et al., 1996; Lee
et al., 1997). We therefore investigated whether the sub-
stitutions in the E protein of FGA/NA d1d affect the
membrane fusion properties of the virion (Despre`s et al.,
1993). Infection of AP61 cells with FGA/89 and FGA/NA
d1d showed no cytopathic effects (data not shown). DEN
viruses can cause fusion of erythrocytes at mildly acidic
pH, and hemagglutination (HA) activity reflects the activ-
ity of the E protein (Despre`s et al., 1993). We found that
both FGA/89 and FGA/NA d1d virions expressed HA
activity in a range of pH values from 6.4 to a maximum at
pH 6.0 (data not shown). These results suggest that
fusogenic properties of FGA/NA d1d and FGA/89 do not
differ significantly.
DEN virus growth in simian cells and mosquito cells
It has been reported that certain mouse-adapted vari-
ants of DEN-1 virus replicate less efficiently than the
parental virus in nonhuman primate cells (Bray et al.,
1998). The capacity of FGA/NA d1d to infect the simian
Vero cell line, a common substrate for DEN virus growth,
did not differ from that of FGA/89 (data not shown). We
examined whether the amino acid substitutions in the E
and NS3 proteins affected viral growth: the mouse-neu-
rovirulent DEN variant replicated as efficiently as the
parental strain in Vero cells (Fig. 2A).
Serial passage of DEN virus in mouse CNS or mam-
malian cell cultures can yield variants with altered infec-
tivity for mosquito vectors (Bhamarapravati and Yoksan,
1997; Jirakananakit et al., 1999). To determine whether
this was the case, FGA/89 and FGA/NA d1d were studied
for their abilities to infect mosquito vectors via the oral
route and to replicate (Vazeille-Falcoz et al., 1999). Fe-
ale Ae. aegypti mosquitoes were fed blood meals con-
aining various doses of highly purified FGA/NA d1d or
GA/89. DEN-1 antigens were detected in mosquito tis-
ues only after virus doses higher than 105 AP61FFU/ml of
meal (data not shown). At a dose of 106 AP61FFU/ml of
lood meal, the infection rate of FGA/NA d1d was sig-
ificantly higher than that of FGA/89 (P 5 0.02) (Fig. 2B).
In vitro analysis showed that the infectivity of FGA/NA
d1d in mosquito cell line AP61 was similar to that of
FGA/89 (data not shown). Cells were infected at a mul-
tiplicity of infection (m.o.i.) of 10 FFU/cell to compare the
abilities of DEN-1 virus trains to produce infectious par-
ticles. Virus production was higher in AP61 cells infected
with FGA/NA d1d than after infection with FGA/89 (P ,
DETERMINANTS OF D0.001, 48 h postinfection) (Fig. 2A). These results indicate
that the mouse-neurovirulent variant replicates as effi-
F
sciently as the parent DEN-1 virus in simian and inverte-
brate cells.
DEN virus-induced apoptosis in Neuro 2a cells
Previous studies have shown that apoptotic cell death
in mouse neuroblastoma cell line Neuro 2a was more
pronounced after infection with mouse neurovirulent
variant FGA/NA d1d than after infection with the parental
strain (Despre`s et al., 1998). To monitor the induction of
apoptosis in DEN virus-infected Neuro 2a cells, the re-
lease of histone-associated cytoplasmic DNA generated
by the internucleosomal degradation of genomic DNA
was analyzed by immunoassay. Neuro 2a cells were
infected with FGA/89 or variant FGA/NA d1d at an m.o.i.
of 400 AP61FFU/cell, which results in optimal infection
(80% of Neuro 2a cells 24 h postinfection) (Despre`s et al.,
1996, 1998). Oligonucleosomal DNA fragments were de-
tected in FGA/NA d1d-infected Neuro 2a cells as early as
27 h postinfection, whereas no significant apoptotic DNA
degradation was observed in FGA/89-infected Neuro 2a
cells during this period (Fig. 3). By 30 h of infection, the
amount of the histone-associated cytoplasmic DNA was
not significantly different between FGA/NA d1d and
FGA/89 (Fig. 3). It appeared, therefore, that the apoptotic
process in Neuro 2a cells progressed more rapidly dur-
ing FGA/NA d1d infection.
DEN virus protein expression in Neuro 2a cells
The infection of mouse neuroblastoma cells with
FGA/89 triggers apoptotic cell death after viral proteins
accumulate in intracellular membranes (Despre`s et al.,
1996). We therefore investigated whether the higher effi-
ciency of FGA/NA d1d to induce apoptosis in Neuro 2a
cells could be attributed to differences in viral protein
production. Previous studies showed that the rate of
DEN-1 virus protein synthesis in mouse neuroblastoma
cells reached a maximum 20 h after infection and then
decreased by 25 h, when apoptotic cell death occurred
(Despre`s et al., 1996). Viral protein synthesis in Neuro 2a
cells infected with FGA/NA d1d and FGA/89 was moni-
tored by radioimmunoprecipitation (RIP) assay 20 and
25 h postinfection (Despre`s et al., 1996). To study the
rocessing of structural and nonstructural proteins, DEN
roteins were immunoprecipitated with anti-DEN-1 virus
yperimmune mouse ascites fluid (HMAF) or with prM-
nd E-specific monoclonal antibodies (mAbs) directed
gainst DEN-1 virus (Despre`s et al., 1993, 1996; Coura-
eot et al., 2000).
Viral protein expression in FGA/89-infected Neuro 2a
ells was clearly detected 20 h postinfection and peaked
y 25 h (Despre`s et al., 1996; Fig. 4, lanes 8/9). Immuno-
recipitation analysis of cell lysates revealed that viral
rotein expression levels were significantly lower in
295IRUS PATHOGENICITYGA/NA d1d-infected Neuro 2a cells at all time points
tudied (Fig. 4, lanes d1d). Indeed, viral protein synthesis
FIG. 2. Growth curves in infected primate and mosquito cells. (A) Vero and AP61 cells were infected with DEN-1 virus FGA/89 M or FGA/NA d1d
f at MOI of 10 AP61FFU/cell. At various times postinfection, virus particles produced in supernatants were tritered on AP61 cells. Each point represents
296 DUARTE DOS SANTOS ET AL.the mean for three determinations. (B) Three independent groups of 100 female Ae. aegypti mosquitoes were fed with 106 AP61FFU of DEN virus/ml
of blood meal. The proportion of infected mosquitoes in each group was determined by IF analysis.
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oonly started in FGA/NA d1d-infected Neuro 2a cells as
late as 25 h postinfection. It appeared, therefore, that the
induction of apoptosis in FGA/NA d1d-infected Neuro 2a
cells at 27 h postinfection paralleled the start of viral
protein synthesis. Conversely, FGA/89-infected Neuro 2a
cells accumulated viral proteins as early as 20 h postin-
fection but did not exhibit signs of cell death before 30 h
(Fig. 3).
Viral RNA production in Neuro 2a cells
We investigated whether differential expression of
FGA/NA d1d proteins was a result of different patterns of
viral RNA synthesis in Neuro 2a cells. The intracellular
virus-specific RNAs were studied by slot-blot hybridiza-
tion, as a measure of plus-strand RNA synthesis. The
overall amount of virus-specific RNA was approximately
10-fold lower in FGA/NA d1d-infected Neuro 2a cells
than in their FGA/89-infected counterparts at 25 h postin-
fection (P , 0.001), calculated relative to the quantities of
enomic RNA extracted from purified virions (Fig. 5).
hus the lag phase of viral RNA production may account
FIG. 3. Kinetics of DEN virus-induced apoptosis in Neuro 2a cells. Ce
were lysed at various times postinfection, and the oligonucleosomal DN
death detection ELISA kit. Optical density was measured at 405 nm. St
r significant (**P , 0.01; ***P , 0.001).
DETERMINANTS OF Dn large part for the reduced FGA/NA d1d protein expres-
ion in Neuro 2a cells.Processing of FGA/NA d1d envelope glycoproteins in
Neuro 2a cells
A causal relationship between the efficiency of DEN-1
virus morphogenesis and the induction of apoptosis
seems likely (Despre`s et al., 1996; Marianneau et al.,
997, 1998a).
To assess whether the amino acid substitutions in
GA/NA d1d may affect the productive folding pathways
f viral envelope glycoproteins in Neuro 2a cells, we
tudied the processing of FGA/NA d1d prM and E pro-
eins that leads to the formation of enveloped viral par-
icles. Previous studies have shown that the time re-
uired for half-maximal (T12) FGA/89 prME heterodimer
formation was 60 min, indicating that this process is slow
(Courageot et al., 2000). Pulse-chase analysis 24 h
postinfection was used to analyze the folding and the
heterodimerization of prM and E in FGA/NA d1d-infected
Neuro 2a cells. The folding of protein E and its assembly
with prM was assessed using mAbs that correctly rec-
ognized folded protein E (anti-E mAb 4D2) and the prME
heterodimer (anti-prM mAb 15H5) (Despre`s et al., 1996;
infected with FGA/89 or FGA/NA d1d or mock-infected (no virus). They
ments released in the cytoplasmic fractions were quantified with a cell
l analysis for DEN virus versus no virus: not significant (n.s., P . 0.05)
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HMAF showed that the prM, E, and NS1 glycoproteins
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2were correctly processed in FGA/NA d1d-infected Neuro
2a cells (Fig. 6, panel HMAF). The T 12 of formation of the
conformation-dependent 4D2 epitope was more than 60
min (Fig. 6, panel 4D2). The T12 of the association between
prM and E was 60 min (Fig. 6, panel 15H5). Thus the
kinetics of the folding and heterodimerization of prM and
E in FGA/NA d1d-infected Neuro 2a cells did not differ
significantly from those of their counterparts in FGA/89-
infected Neuro 2a cells (Courageot et al., 2000). The
greater efficiency of FGA/NA d1d at inducing apoptosis
in Neuro 2a cells was not linked to an obvious defect in
the first steps of viral morphogenesis.
DEN virus growth in HepG2 cells
The presence of viral antigens inside human hepato-
cytes indicates that these cells may be susceptible to
infection by DEN virus (Marianneau et al., 1996; Couve-
lard et al., 1999). DEN-1 virus strain FGA/89 has been
shown to replicate in human hepatoma HepG2 cells
(Marianneau et al., 1996). We examined whether FGA/89
and its mouse-neurovirulent variant differed in their ca-
pacity to grow in HepG2 cells. The efficiencies of infec-
tion of both DEN-1 viruses were first examined by immu-
nofluorescence (IF) assay. HepG2 cells were infected at
an m.o.i. of 10–80 AP61FFU/cell. Inoculation with 40
AP61FFU/cell was needed to infect 50% of HepG2 cell
monolayers with FGA/89 as monitored by immunostain-
FIG. 4. Kinetics of DEN virus protein production in Neuro 2a cells. C
P61FFU/cell or mock-infected (No). Proteins in cells were labeled for
ell lysates were immunoprecipitated with anti-DEN-1 virus HMAF (H
nalyzed by SDS–15% PAGE under reducing conditions.
98 DUARTE DOing of viral antigens 25 h postinfection (Fig. 7A). In con-
trast, no more than 20% of FGA/NA d1d-infected HepG2cells were positive for viral antigens at the highest m.o.i.
tested (Fig. 6A). Thus FGA/89 and its mouse-neuroviru-
lent variant differed in their efficiency of infection of
human hepatoma cells. The difference may be due to a
lag phase before viral protein production. To determine
whether this was the case, HepG2 cells were infected at
an m.o.i. of 40 AP61FFU/cell, and viral protein production
as monitored by IF staining at 25 and 30 h postinfec-
ion. The number of FGA/89-infected HepG2 cells re-
ained constant between 25 and 30 h postinfection,
hereas the proportion of cells positive for FGA/NA d1d
ntigens increased from 15% to 35% (Fig. 7B). These
esults suggest that FGA/NA d1d growth was delayed in
epG2 cells.
iral RNA synthesis in HepG2 cells
Viral protein synthesis in HepG2 cells progressed
ore slowly after infection with FGA/NA d1d. To investi-
ate whether the delay was due to altered viral RNA
ynthesis, the production of viral RNA was examined in
epG2 cells infected with FGA/NA d1d and FGA/89 at an
.o.i. of 40 AP61FFU/cell at various times postinfection.
The overall amount of viral RNA, and therefore presum-
ably RNA synthesis, was significantly lower in HepG2
cells infected with FGA/NA d1d than in those infected
with FGA/89 within the first 25 h of infection (P , 0.05)
(Fig. 8A). The rate of viral RNA synthesis in FGA/NA
re infected with FGA/89 (89) or FGA/NA d1d (d1d) at an m.o.i. of 400
various times postinfection. Cells were lysed, and viral proteins from
nti-prM mAb 14E9 (14E9), or anti-E mAb 9D12 (9D12). Samples were
TOS ET AL.ells we
1 h at
S SANd1d-infected HepG2 cells was significantly increased
between 25 and 30 h postinfection (Fig. 8A) (P , 0.05).
w A extraThese results suggest that viral RNA synthesis was de-
layed in FGA/NA d1d-infected HepG2 cells. The cyto-
pathic effects in FGA/89-infected HepG2 cells may con-
tribute to the lower amount of viral RNA 30 h postinfec-
tion (Fig. 8A; Marianneau et al., 1997, 1998b).
DEN virus-induced apoptosis in HepG2 cells
Infection of the human hepatoma cell line HepG2 with
DEN-1 virus strain FGA/89 results in extensive apoptosis
FIG. 5. Viral RNA production in Neuro 2a cells. Slot-blot hybridization
Neuro 2a cells at 25 h postinfection (B). Viral RNA were hybridized with
ith a PhosphorImager (left). (A) Two independent samples of viral RN
Two independent samples of total RNA extracted from infected cells.
DETERMINANTS OF Dafter 40 h of infection (Marianneau et al., 1997, 1998b). We
examined whether FGA/89 and its mouse-adapted neu-rovirulent variant differed in their efficiency to induce
apoptosis in hepatoma cells. HepG2 cells were infected
with FGA/89 or FGA/NA d1d at an m.o.i. of 40 AP61FFU/
cell, and apoptotic DNA degradation was quantitatively
assayed by immunoassay. The amount of histone-asso-
ciated cytoplasmic DNA fragments was significantly
higher in FGA/89-infected HepG2 cells than in FGA/NA
d1d-infected HepG2 cells 45 h postinfection (P 5 0.001)
(Fig. 8B). This suggests that apoptosis was much less
A/89 genomic RNA (A) or virus-specific RNAs from DEN virus-infected
beled PCR product specific for DEN-1 virus (right) and then quantitated
cted from various amounts of purified infective particles (AP61FFU). (B)
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shown).
DEN virus production in HepG2 cells
The production of infectious particles in DEN virus-
infected human hepatoma cells is very low, suggesting
that viral morphogenesis is an inefficient process in this
cell type (Marianneau et al., 1996, 1998b). We examined
whether the lower cytotoxicity of FGA/NA d1d for HepG2
cells results in an increased viral yield. HepG2 cell
monolayers (2.5 3 105 cells/well) were infected with
FGA/89 or FGA/NA d1d at an m.o.i. of 20 AP61FFU/cell,
nd the release of infective particles was assayed at
arious times postinfection. Progeny virus production in
GA/89-infected HepG2 cells was similar at 24 and 48 h
ostinfection (6.5 [62.5] 3 103 AP61FFU/ml), whereas in-
fective particles accumulated in FGA/NA d1d-infected
HepG2 cells during the same interval to 2.0 (60.2) 3 104
AP61FFU/ml at 48 h (P , 0.01).
EN virus protein expression in HepG2 cells
We examined whether the differences in DEN-1 virus
roduction in HepG2 cells were also due to differences
n viral protein processing. Viral protein production in
epG2 cells infected with FGA/NA d1d and FGA/89 was
FIG. 6. Kinetics of FGA/NA d1d envelope glycoprotein processing in
at 24 h postinfection and chased for various times. Cells were lysed, a
virus HMAF (HMAF), anti-prM mAb 15H5 (15H5), or anti-E mAb 4D2 (4D
300 DUARTE DOonitored by RIP assay at various times postinfection.
he major DEN proteins were clearly detected at 25 h of
n
gnfection (Fig. 9, HMAF). No obvious differences were
bserved in viral protein processing between FGA/89
nd FGA/NA d1d. Detailed RIP analysis showed that
nti-DEN-1 virus HMAF immunoprecipitated a small
mount of labeled protein E (Fig. 9, HMAF). This sug-
ests that E production from DEN-1 structural polypro-
ein was significantly impaired in HepG2 cells.
To study the processing of DEN-1 virus E protein in
epG2 cells, samples were immunoprecipitated with the
nti-E mAbs 9D12 and 8C2. mAb 9D12 recognizes a
onformation-independent epitope within the domain III
hat is accessible in intracellular forms of E and in DEN-1
irions (Me´gret et al., 1992; Despre`s et al., 1993; Coura-
eot et al., 2000). The immunoreactivity of mAb 9D12 with
GA/89 and FGA/NA d1d E proteins did not differ signif-
cantly at 30 h postinfection (Fig. 9, 9D12). However,
iscrete labeled polypeptides migrating faster than pro-
ein E were clearly detected (Fig. 9, 9D12), suggesting a
ossible degradation of DEN E glycoprotein in HepG2
ells. Anti-E mAb 8C2 binds to a linear epitope within the
omain II of DEN-1 virus E protein and recognizes in-
ompletely folded species of protein E (Me´gret et al.,
992; Despre`s et al., 1993, 1996; Courageot et al., 2000).
IP analysis with the anti-E mAb 8C2 showed that a large
mount of prM interacted with E to form a heterocomplex
Fig. 9, 8C2). This unexpected finding suggests that
a cells. Cells infected with FGA/NA d1d were pulse-labeled for 10 min
l proteins from cell lysates were immunoprecipitated with anti-DEN-1
ples were analyzed by SDS–15% PAGE under nonreducing conditions.
TOS ET AL.Neuro 2
S SANewly synthesized DEN envelope proteins may aggre-
ate in HepG2 cells.
(A) orThe productive assembly of DEN envelope glycopro-
teins was assessed using anti-prM mAb 14E9, which
recognizes the prME heterodimer. The rate of prM pro-
duction in DEN virus-infected HepG2 cells increased
slightly during the first 30 h of infection (Fig. 9, compare
panels 25 and 30, 14E9). RIP assay with the anti-prM
mAb 14E9 revealed that prM and E heterodimerized in
FGA/NA d1d-infected HepG2 cells within 30 h of infec-
FIG. 7. Viral growth in infected HepG2 cells. Cells infected with DEN
for viral protein production. Viral antigens were visualized by an
antigen-positive cells in three sets of cell monolayers 25 h postinfection
not significant (n.s., P . 0.05) or significant (***P , 0.001).
DETERMINANTS OF Dtion (Fig. 9, lanes d1d, 14E9). In contrast, only a very
small amount of FGA/89 E protein coprecipitated withprM (Fig. 9, lanes 89, 14E9). This suggests that the
formation of DEN-1 envelope glycoprotein complexes
was more efficient in HepG2 cells infected with FGA/NA
d1d than in those infected with the parental strain.
DISCUSSION
Neurovirulent variant FGA/NA d1d was generated dur-
at various m.o.i.s (A) or an m.o.i. of 40 AP61FFU/cell (B) were analyzed
y with anti-DEN-1 virus HMAF. The proportion is shown of DEN
at various times postinfection (B). Statistical analysis 30 h versus 25 h:
301IRUS PATHOGENICITY-1 virus
IF assa
EN-1 Ving the adaptation of the human isolate of DEN-1 virus
strain FGA/89 to grow in newborn mouse brain and
ted (Nomosquito cells in vitro (Despre`s et al., 1998). We identi-
fied the amino acid changes in the mouse-passaged,
neurovirulent variant of FGA/89 that are potentially re-
sponsible for the acquisition of mouse neurovirulence.
FGA/NA d1d has three amino acid substitutions in the
envelope E protein and one in the viral RNA helicase
NS3. It is interesting to note that for both viral proteins,
the identified amino acid substitutions map to the inter-
faces between structural domains (Fig. 1).
FIG. 8. Viral RNA synthesis and DEN virus-induced apoptosis in
postinfection (A) and release of histone-associated DNA fragments 45 h
infected cells. Experiments were performed as described in the legend
sets of HepG2 cell monolayers infected with DEN-1 virus or mock-infec
DNA fragments was quantified as described in the legend to Fig. 2.
302 DUARTE DOThe conservative amino acid substitutions at positions
E196 and E365 map to the interfaces of domains I and IIand of domains I and III, respectively (Fig. 1A). Previous
reports have shown that mutations in the interfaces be-
tween structural domains of the E protein may influence
the pathogenicity of flaviviruses (Rey et al., 1995). The
nonconservative amino acid substitution at position
E405 maps to H1pred next to the membrane anchor region
(Allison et al., 1999). It has been suggested that formation
of DEN envelope glycoprotein complexes is mediated by
domains in the C-terminus of E (Allison et al., 1999; Wang
cells. Slot-blot hybridization of virus-specific RNA at various times
fection (B). (A) Three independent samples of total RNA extracted from
3. RNAs were hybridized with 32P-labeled plasmid pCI/prM-E. (B) Three
virus) were analyzed for apoptotic cell death. The release of apoptotic
TOS ET AL.HepG2
postin
to Fig.
S SANet al., 1999). The Thr405-to-Ile substitution alters the
hepta-repeat pattern of hydrophobic and polar residues
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the stem region of protein E.
The active flavivirus RC is composed of the NS1, NS2A,
NS3, NS4A, and NS5 proteins and viral RNA template
(Chen et al., 1997; Khromykh et al., 1999a, b; Mackenzie
et al., 1999), and cell proteins that interact with the
terminal stem-loop of the 39 UTR of genomic RNA may
also be involved (Blackwell and Brinton, 1997). The com-
position of the RCs yielding new viral RNAs had been
suggested to be similar early and late in infection (Khro-
mykh et al., 1999b). The viral RNA helicase activity of NS3
is regulated by the RNA-dependent RNA polymerase
NS5 in the flavivirus RC (Kapoor et al., 1995; Chen et al.,
1997; Rice, 1996; Cui et al., 1998; Khromykh et al., 1999a,
b). The nonconservative Leu-to-Ser change at position
NS3-435 in FGA/NA d1d virus has not been previously
described in any DEN-1 virus strains. We have used the
known structure of the helicase domain of protein NS3
from HCV to localize the amino acid substitution in
DEN-1 NS3 protein in the context of three-dimensional
FIG. 9. DEN-1 virus protein expression in HepG2 cells. Cells were
infected with FGA/89 (89) or FGA/NA d1d (d1d) at an m.o.i. of 40
AP61FFU/cell or mock-infected (No). Proteins in cells were labeled for
1 h at 25 h postinfection (top) or various times postinfection (bottom).
Cells were lysed, and viral proteins were immunoprecipitated with
normal mouse serum (NMS), anti-DEN-1 virus HMAF (HMAF), anti-prM
mAb 14E9 (14E9), or anti-E mAbs 8C2 (8C2) and 9D12 (9D12). Samples
were analyzed by SDS–15% PAGE under reducing conditions.
DETERMINANTS OF Dstructure of the folded polypeptide (Fig. 1B). The amino
acid substitution in FGA/NA d1d NS3 protein maps to thetip of the b-hairpin emerging from the RNA binding do-
main to contact the C-terminal, a-helical domain. The
onnection between the two domains via the b-hairpin
may be important for the NTPase/helicase activity of the
NS3, which is thought to change conformation on ATP
hydrolysis to unwind viral RNA. It is possible that the
radical Leu435-to-Ser change at the interface of the RNA
inding and C-terminal, a-helical domains may affect the
GA/NA d1d NS3 protein activities that are required in
EN-1 virus replicative functions. Interestingly, this
mino acid substitution was also found in a second
ouse-passaged, neurovirulent FGA/89 variant, FGA/NA
5c (Despre`s et al., 1998).
All four amino acid substitutions in FGA/NA d1d virus
ie at regions that are likely to be important for confor-
ational changes during the virus life cycle. The amino
cid changes at positions E196, E405, and NS3-435 were
lso identified in FGA/NA a5c (Despre`s et al., 1998).
hich amino acid contributes to the acquisition of
ouse neurovirulence is not yet clear. We speculate that
he identified amino acid changes in the ectodomain of
EN-1 E protein may account for the differences in the
athogenesis of virus infection observed in vivo. A major
eterminant of DEN-2 virus mouse neurovirulence was
dentified at position E126 (Gualano et al., 1998). Two
mino acid substitutions in domain II result in the acqui-
ition of mouse neurovirulence of DEN-2 virus strain
ew Guinea C (Bray et al., 1998). Furthermore, the
he402-to-Leu amino acid change in DEN-4 E protein
onfers the mouse neurovirulence phenotype to a non-
eurovirulent virus strain (Bray et al., 1998). These find-
ings support the notion that genetic determinants in DEN
E protein play an essential role in increasing virulence in
vivo. A full-length infectious cDNA for DEN-1 virus strain
FGA/89 with the identified amino acid substitutions is
needed to provide direct evidence for their contribution
to the pathophysiology of newborn mice in the response
to DEN virus infection.
We have examined the contribution of the E and NS3
determinants in DEN-1 virus pathogenicity in vitro. The rate
of viral protein production in mouse neuroblastoma cells
infected with FGA/NA d1d was much lower than that in
cells infected with the parental strain. The differences in
viral protein production were essentially due to differences
in the rate of viral RNA production. Because 59 and 39 UTRs
of genomic RNA are identical in FGA/89 and FGA/NA d1d,
presumably the change at position NS3-435 alters the ac-
tivity of RCs in mouse neuroblastoma cells. It has been
shown that, for the bovine viral diarrhea virus (Flaviviridae),
the NS3 NTPase/helicase activity is essential for the syn-
thesis of minus-strand RNA (Gu et al., 2000). One way of
identifying the role of NS3-435 in the functional activity of
RC is to develop a functionally active DEN-1 RC from rep-
licon RNA (Khromykh et al., 1999a, b).
303IRUS PATHOGENICITYThe titers of progeny virus in mouse neuroblastoma
cells infected with FGA/89 and FGA/NA d1d were similar
S SAN(Despre`s et al., 1998), despite viral protein production
being different. Our data suggest that the productive
assembly pathways of FGA/NA d1d envelope glycopro-
teins were more efficient than those for the parental
strain. It has been proposed that domain II and the stem
anchor of protein E influence the efficiency of oligomer-
ization of the two viral envelope glycoproteins (Rey et al.,
1995; Allison et al., 1999). Thus amino acid changes at
positions E196 and E405 could facilitate the oligomeric
assembly of DEN-1 envelope glycoproteins in mouse
neuroblastoma cells. The involvement of the amino acid
changes in E could be confirmed through the use of
stable cell clone N2aprM1E expressing recombinant
FGA/89 envelope glycoproteins under the control of an
inducible, exogenous promoter (Courageot et al., 2000).
An important finding was that the mouse neurovirulent
DEN-1 virus variant induced apoptosis more rapidly than
the parental strain in mouse neuroblastoma cells, albeit
yielding much lower amounts of viral proteins. Consis-
tent with the notion that amino acids substitutions in
FGA/NA d1d E protein facilitate viral morphogenesis in
the ER, a more efficient assembly of virus particles might
promote the induction of apoptosis by causing a more
severe stress than that due to infection with the parental
strain. Accumulation of DEN envelope glycoprotein com-
plexes in the ER membranes has been suggested to
cause a stress activating the apoptotic pathway (De-
spre`s et al., 1996; Marianneau et al., 1998a).
The amino acid substitutions in FGA/NA d1d E and
NS3 proteins neither affected its capacity to replicate in
primate cells nor caused lower infectivity for mosquito
vectors. We postulate that the mouse neurovirulent vari-
ant has the ability to be transmitted to primates by the
vector mosquitoes Ae. aegypti. It has been suggested
that the acquisition of mouse neurovirulence of DEN
virus is directly or indirectly associated with attenuation
in primates (Bray et al., 1998). We therefore examined
whether FGA/89 and its mouse neurovirulent variant dif-
fered in their capacity to grow in human hepatocytes. We
observed that the kinetics of FGA/89 and FGA/NA d1d
virus replication were different. FGA/NA d1d infection
was characterized by the late accumulation of intracel-
lular antigens. Altered viral growth may account for the
lower efficiency of FGA/NA d1d virus infection in human
hepatoma cells. The rate of viral RNA synthesis was low
in FGA/NA d1d virus-infected hepatoma cells during the
first 25 h of infection and then increased abruptly by 30 h.
In contrast, viral RNA synthesis was maintained at a
constant level in FGA/89-infected hepatoma cells during
the same period. Thus, a Leu435-to-Ser amino acid
change in FGA/NA d1d NS3 protein could modulate the
efficiency of RCs to catalyse the synthesis of new RNA
molecules in human hepatoma cells, as already ob-
served in mouse neuroblastoma cells.
304 DUARTE DOAnalysis of the viral proteins suggested that most
DEN-1 E protein was degraded in human hepatoma
m
acells. However, DEN-1 virus envelope glycoproteins may
aggregate, leading to a nonproductive pathway. It has
recently been shown that HCV glycoproteins E1 and E2
produced in human hepatoma cells aggregate in ER-like
structures (Choukhi et al., 1999). The aggregation of
DEN-1 envelope glycoproteins might involve incorrect
disulfide linkages in the ER (Molinari and Helenius,
1999). The conversion of soluble proteins into insoluble
aggregates may have a significant effect on cell func-
tions (Welch and Gambetti, 1998). The formation of
DEN-1 glycoprotein aggregates may account for the in-
duction of apoptosis in human hepatoma cells.
FGA/NA d1d has a greater capacity than the parental
strain to produce virus progeny in human hepatoma
cells. This difference paralleled the higher level of
FGA/NA d1d prME heterodimers, probably due to a
greater capacity of FGA/NA d1d E protein to associate
with prM as a consequence of amino acid substitutions.
The extent of apoptosis was much lower in FGA/NA
d1d-infected human hepatoma cells than in cells in-
fected with the parental strain. A greater efficiency of
folding and oligomeric assembly of DEN-1 envelope gly-
coproteins may be largely responsible for the lower cy-
totoxicity of FGA/NA d1d in restricting the overloading of
DEN-1 glycoprotein aggregates in the ER membranes. It
is also possible that altered viral growth accounts for the
lower cytotoxicity of FGA/NA d1d for human hepatoma
cells.
In conclusion, the identified substitution in DEN-1 RNA
helicase NS3 might alter the efficiency of viral RNA
production by RCs during the first stages of virus repli-
cation. The amino acid substitutions at the interfaces of
domains I, II, and III and in the H1pred of the E protein may
account for the differences in DEN-1 progeny titers by
facilitating virus assembly. Previous reports indicate that
DEN virus mutations that affect viral growth may contrib-
ute to attenuation in humans (Bhamarapravati et al.,
1987; Edelman et al., 1994; Bray et al., 1998). Our data
suggest that differences in virus life cycle influence the
pathogenicity of DEN-1 virus. Altered viral growth cou-
pled with a greater efficiency of viral morphogenesis
triggered a rapid induction of apoptosis in mouse neu-
rons but caused attenuation in human hepatocytes in
vitro. The discrepancy in DEN-1 virus pathogenicity may
also be related to particular apoptotic pathways that are
activated in response to the viral replicative functions
(Roulston et al., 1999). Indeed, DEN-1 virus infection of
human hepatoma cells activates the transcription factor
NF-kB, which in turn, promotes the induction of apopto-
sis (Marianneau et al., 1997). We are currently investigat-
ing whether the lower cytotoxicity of FGA/NA d1d for
human hepatoma cells is the result of variations in the
levels of NF-kB activity. An understanding of the specific
TOS ET AL.echanisms by which DEN virus replication induces
poptosis in mouse neurons and human hepatocytes will
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EN-1 Vgive new insights into the contribution of the E and NS3
determinants in DEN-1 virus pathogenicity.
MATERIALS AND METHODS
Cells and DEN-1 viruses
The mosquito Ae. pseudoscutellaris cell line AP61, the
mouse neuroblastoma cell line Neuro 2a, the human
hepatoma cell line HepG2, and the nonhuman primate
cell line Vero were propagated as described previously
(Despre`s et al., 1993, 1996; Marianneau et al., 1996).
The derivation of the DEN-1 viruses FGA/89 and
FGA/NA d1d has been previously reported (Despre`s et
al., 1993, 1998). The production and purification of DEN
virus from AP61 cell monolayers and virus titration on
AP61 cells by focus immunodetection assay (FIA) were
performed as previously described (Despre`s et al., 1993).
Virus titers are expressed as AP61FFU/ml.
IF assay
For IF assay, cells were fixed with 3% paraformalde-
hyde in PBS for 20 min and permeabilized with 0.1%
Triton X-100 in PBS for 5 min. The fixed cells were
incubated for 20 min with a 1:100 dilution of anti-DEN-1
virus HMAF. FITC-conjugated goat anti-mouse immuno-
globulin (Sigma Chemical Co., St. Louis, MO) was used
as the second antibody.
Virus infectivity in Ae. aegypti
The Paea strain of Ae. aegypti provided by Institut
Louis Malarde (Tahiti, French Polynesia) and reared in
Paris since 1994 was used for the oral infection experi-
ments. The mosquitoes were maintained in the labora-
tory at 28 6 1°C with 80% relative humidity with a 16/8-h
photoperiod. Larvae were fed with yeast tablets, and
adults were fed with 10% sucrose solution.
The oral susceptibility of females was tested by a
feeding protocol as described elsewhere (Vazeille-Fal-
coz et al., 1999). Briefly, 5- to 7-day-old females were
deprived of sucrose solution 1 day before the infectious
meal and then allowed to feed for 20 min through a
chicken skin membrane covering an apparatus contain-
ing the feeding mixture maintained at 37°C. The infec-
tious meal consisted of 70% washed rabbit erythrocytes,
30% virus suspension, and ATP (as a phagostimulant) at
a final concentration of 5 3 1023 M. Only fully engorged
emales were transferred to small cardboard containers
nd maintained at 28 6 1°C for 14 days. Surviving
emales were killed and tested for the presence of
EN-1 virus by IF assay of head squashes as previously
escribed (Kuberski and Rosen, 1977).
iral RNA analysis
DETERMINANTS OF DFor analysis of viral RNA, the cDNA nucleotide region
025–2325 of the DEN-1 virus coding sequence (De-
1
spre`s et al., 1993) was amplified from the plasmid pCI/
rM-E by PCR (Despre`s et al., 1998). The PCR product
ontaining DEN-1 virus sequence and plasmid pCI/
rM-E was radiolabeled with [a-32P]dCTP (3000 Ci/mmol)
sing the Nick Translation Kit (Roche Molecular Bio-
hemicals, Mannheim, Germany). Genomic RNA ex-
racted from purified DEN virus and total RNA from in-
ected cells were prepared with RNA-PLUS reagent
Quantum Bioprobe, Montrevil, France) according to the
anufacturer’s instructions. RNA samples were dena-
ured at 65°C in MOPS buffer containing 50% formamide
nd 30% formaldehyde. Viral RNA was analyzed by slot-
lot hybridization on a Hybond-N nylon membrane (Am-
rsham Pharmacia/Biotech, Orsay, France) according to
he manufacturer’s instructions and then quantified with
PhosphorImager (Molecular Dynamics, Sunnyvale,
A).
iral protein analysis
Cells were starved for 1 h in DMEM without methio-
ine and cysteine (ICN Biomedicals, Inc., Irvine, CA) and
hen labeled for 1 h with 100 mCi/ml Tran35S-label (ICN
Biomedicals Inc.). Cells were lysed with ice-cold RIP
assay buffer, and an RIP assay was performed as previ-
ously described (Despre`s et al., 1993, 1995, 1996). For
pulse-chase analysis, cells were pulse-labeled with 500
mCi/ml Tran35S-label and chased as previously de-
cribed. Cells were lysed with ice-cold 1% Triton X-100 in
NI buffer, and an RIP assay was performed as previ-
usly described (Despre`s et al., 1995; Courageot et al.,
000). Samples were analyzed by SDS–polyacrylamide
el electrophoresis (SDS–PAGE).
poptotic cell death detection
To detect apoptotic cell death, oligonucleosomal DNA
ragments in cell lysates were quantified by ELISA (Cell
eath Detection ELISAPLUS kit; Roche Molecular Bio-
hemicals) as previously described (Despre`s et al.,
998). Optical density was measured at 405 and 492 nm
s described in the manufacturer’s manual.
ucleotide sequence by RT-PCR
Monolayers of AP61 cells were used to prepare highly
urified DEN-1 virus stocks from which genomic RNA
as extracted. The nucleotide sequences of the struc-
ural protein genes in FGA/89 and FGA/NA d1d have
een determined previously (Despre`s et al., 1993, 1998).
Genomic RNA was extracted from purified DEN-1 virus
sing a standard phenol–chloroform method. Two over-
apping cDNA products were prepared from the purified
NA using Expand Reverse Transcriptase (Roche Molec-
lar Biochemicals) as described in the manufacturer’s
anual. The cDNA nucleotide regions 1–5277 and 5125–
305IRUS PATHOGENICITY0735 were amplified according the manufacturer’s in-
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were purified by High Pure PCR Product Purification Kit
(Roche Molecular Biochemicals). Both strands of the
cDNA/PCR products were sequenced using the Thermo
Sequanase Kit (Amersham, Arlington Heights, IL). Se-
quences from the 59 and the 39 noncoding regions were
obtained after uncapping and RNA ligation as described
elsewhere (Mandl et al., 1991).
Three-dimensional structures of the E and NS3
proteins
The E protein from the related TBE virus (Rey et al.,
1995) which shares about 40% sequence identity, was
used as the reference structure. The DEN-1-sE (strain
FGA/89) and TBE-sE (strain Neudorfl) sequences were
aligned using the program SIM (Huang and Miller, 1991)
and modified by hand so that all insertions and deletions
would lie within predicted loop regions. Modeling was
done with the program MODELLER (Sali and Blundell,
1993). For comparative modeling, MODELLER derives a
set of spatial constraints from the reference structure or
structures and then applies these restraints to the target
sequence, based on the sequence alignment. The result-
ing structure is displayed using the program RIBBONS
(Carson, 1987).
The NS3 protein from HCV (Protein Data Bank acces-
sion code 1a1v), which shares about 25% sequence
identity, was used as the reference structure (Kim et al.,
1998). Program PSI-BLAST (Altschul et al., 1997) was
used to obtain an alignment of the NS3 helicase region
using the available sequences of members of the Flavi-
viridae (SwissProt database). No attempt was made to
model the actual sequence of DEN-1 virus onto the HCV
sequence. Several stretches of conserved sequence el-
ements scattered throughout the polypeptide (some
common to nucleic acid helicases in general and others
restricted to the Flaviviridae) are convincing landmarks
to predict the position of DEN-1 NS3-435 in the NS3
helicase region of HCV (Phe438).
tatistical analysis
Data for groups or samples were compared by Fish-
r’s and Yates’ t tests, and P , 0.05 was considered
tatistically significant.
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